Ph.D John Woock - 17 Jan 2023 Form 4 Insider Report for Axonics, Inc.

Role
EVP, Chief Mktg/Strtgy Officer
Signature
/s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
Issuer symbol
N/A
Transactions as of
17 Jan 2023
Net transactions value
-$1,506,482
Form type
4
Filing time
19 Jan 2023, 19:07:10 UTC
Previous filing
12 Sep 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $3,687 +2,793 +6.1% $1.32* 48,769 17 Jan 2023 Direct
transaction AXNX Common Stock Sale $188,855 -2,793 -5.7% $67.62 45,976 17 Jan 2023 Direct F1
transaction AXNX Common Stock Options Exercise $537 +378 +0.82% $1.42* 46,354 17 Jan 2023 Direct
transaction AXNX Common Stock Sale $25,519 -378 -0.82% $67.51 45,976 17 Jan 2023 Direct F1
transaction AXNX Common Stock Options Exercise $212,850 +15,000 +33% $14.19* 60,976 17 Jan 2023 Direct
transaction AXNX Common Stock Sale $1,009,384 -15,000 -25% $67.29 45,976 17 Jan 2023 Direct F1
transaction AXNX Common Stock Options Exercise $310,976 +12,044 +26% $25.82 58,020 17 Jan 2023 Direct
transaction AXNX Common Stock Sale $810,772 -12,044 -21% $67.32 45,976 17 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -12,044 -77% $0.000000 3,581 17 Jan 2023 Common Stock 12,044 $25.82 Direct F2
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -15,000 -49% $0.000000 15,555 17 Jan 2023 Common Stock 15,000 $14.19 Direct F3
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -378 -100% $0.000000* 0 17 Jan 2023 Common Stock 378 $1.42 Direct F4
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -2,793 -100% $0.000000* 0 17 Jan 2023 Common Stock 2,793 $1.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $67.17 to $67.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on December 12, 2020 and the remainder vest at a rate of 1/36th per month commencing on January 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F3 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on January 30, 2020, and the remainder vest at a rate of 1/36th per month commencing on February 1, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F4 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on August 25, 2018 and the remainder vest at a rate of 1/36th per month commencing on September 1, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F5 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on July 5, 2018 and the remainder vest at a rate of 1/36th per month commencing on August 1, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.